BRK-B vs INDB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
INDB presents a compelling value opportunity, trading below both its Graham Number ($85.05) and its growth-based intrinsic value ($130.98). While the Piotroski F-Score of 4/9 indicates only stable financial health, the company is exhibiting explosive growth with YoY revenue increases of 47.10% and strong earnings momentum. Despite bearish technical trends and minimal insider buying, the low Price-to-Book ratio (1.10) and a significant drop in forward P/E (9.58) suggest the market is underpricing its growth trajectory.
Compare Another Pair
Related Comparisons
BRK-B vs INDB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Independent Bank Corp. (INDB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.